Annual FCF
-$46.12 M
+$47.08 M+50.51%
December 31, 2023
Summary
- As of February 10, 2025, LAB annual free cash flow is -$46.12 million, with the most recent change of +$47.08 million (+50.51%) on December 31, 2023.
- During the last 3 years, LAB annual FCF has fallen by -$17.98 million (-63.92%).
- LAB annual FCF is now -634.71% below its all-time high of -$6.28 million, reached on December 1, 2013.
Performance
LAB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$30.12 M
+$10.86 M+26.50%
September 30, 2024
Summary
- As of February 10, 2025, LAB quarterly free cash flow is -$30.12 million, with the most recent change of +$10.86 million (+26.50%) on September 30, 2024.
- Over the past year, LAB quarterly FCF has dropped by -$15.98 million (-113.06%).
- LAB quarterly FCF is now -2696.90% below its all-time high of $1.16 million, reached on December 1, 2013.
Performance
LAB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$148.51 M
-$17.81 M-13.62%
September 30, 2024
Summary
- As of February 10, 2025, LAB TTM free cash flow is -$148.51 million, with the most recent change of -$17.81 million (-13.62%) on September 30, 2024.
- Over the past year, LAB TTM FCF has dropped by -$102.39 million (-222.02%).
- LAB TTM FCF is now -4383.91% below its all-time high of -$3.31 million, reached on March 1, 2010.
Performance
LAB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
LAB Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.5% | -113.1% | -222.0% |
| 3 y3 years | -63.9% | -196.3% | -126.8% |
| 5 y5 years | -80.3% | -196.3% | -126.8% |
LAB Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.5% | -303.5% | +52.4% | -222.0% | at low |
| 5 y | 5-year | -63.9% | +50.5% | -778.0% | +52.4% | -653.4% | at low |
| alltime | all time | -634.7% | +50.5% | -2696.9% | +52.4% | -4383.9% | at low |
Standard BioTools Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$30.12 M(-26.5%) | -$148.51 M(+13.6%) |
| Jun 2024 | - | -$40.99 M(-35.2%) | -$130.70 M(+30.9%) |
| Mar 2024 | - | -$63.26 M(+347.4%) | -$99.88 M(+116.6%) |
| Dec 2023 | -$46.12 M(-50.5%) | -$14.14 M(+14.8%) | -$46.12 M(-11.2%) |
| Sep 2023 | - | -$12.32 M(+21.1%) | -$51.91 M(-20.7%) |
| Jun 2023 | - | -$10.17 M(+7.1%) | -$65.47 M(-24.1%) |
| Mar 2023 | - | -$9.49 M(-52.4%) | -$86.23 M(-7.5%) |
| Dec 2022 | -$93.19 M(+62.6%) | -$19.94 M(-23.0%) | -$93.19 M(+15.4%) |
| Sep 2022 | - | -$25.88 M(-16.3%) | -$80.72 M(+22.2%) |
| Jun 2022 | - | -$30.93 M(+87.9%) | -$66.05 M(+22.4%) |
| Mar 2022 | - | -$16.46 M(+120.5%) | -$53.96 M(-5.9%) |
| Dec 2021 | -$57.33 M(+103.8%) | -$7.46 M(-33.3%) | -$57.33 M(-10.8%) |
| Sep 2021 | - | -$11.20 M(-40.5%) | -$64.30 M(+10.8%) |
| Jun 2021 | - | -$18.84 M(-5.0%) | -$58.04 M(+36.1%) |
| Mar 2021 | - | -$19.82 M(+37.3%) | -$42.63 M(+51.5%) |
| Dec 2020 | -$28.13 M(-25.5%) | - | - |
| Dec 2020 | - | -$14.44 M(+192.4%) | -$28.13 M(+42.7%) |
| Sep 2020 | - | -$4.94 M(+43.9%) | -$19.71 M(-4.6%) |
| Jun 2020 | - | -$3.43 M(-35.6%) | -$20.67 M(-8.8%) |
| Mar 2020 | - | -$5.33 M(-11.5%) | -$22.67 M(-39.9%) |
| Dec 2019 | -$37.74 M(+47.6%) | - | - |
| Dec 2019 | - | -$6.02 M(+2.1%) | -$37.74 M(+16.6%) |
| Sep 2019 | - | -$5.89 M(+8.5%) | -$32.38 M(+5.3%) |
| Jun 2019 | - | -$5.43 M(-73.4%) | -$30.75 M(+3.5%) |
| Mar 2019 | - | -$20.40 M(+2999.7%) | -$29.72 M(+16.2%) |
| Dec 2018 | -$25.57 M(-0.5%) | -$658.00 K(-84.6%) | -$25.57 M(+4.5%) |
| Sep 2018 | - | -$4.26 M(-3.1%) | -$24.48 M(-14.9%) |
| Jun 2018 | - | -$4.40 M(-72.9%) | -$28.75 M(-12.3%) |
| Mar 2018 | - | -$16.25 M(-3853.6%) | -$32.79 M(+27.5%) |
| Dec 2017 | -$25.71 M | $433.00 K(-105.1%) | -$25.71 M(-31.6%) |
| Sep 2017 | - | -$8.54 M(+1.2%) | -$37.57 M(-14.6%) |
| Jun 2017 | - | -$8.43 M(-8.1%) | -$44.01 M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$9.18 M(-19.6%) | -$44.45 M(+0.6%) |
| Dec 2016 | -$44.20 M(-2.6%) | -$11.42 M(-23.7%) | -$44.20 M(-2.0%) |
| Sep 2016 | - | -$14.97 M(+68.7%) | -$45.12 M(+4.6%) |
| Jun 2016 | - | -$8.87 M(-0.7%) | -$43.13 M(-0.8%) |
| Mar 2016 | - | -$8.94 M(-27.6%) | -$43.49 M(-4.2%) |
| Dec 2015 | -$45.38 M(+51.2%) | -$12.34 M(-5.0%) | -$45.38 M(+19.3%) |
| Sep 2015 | - | -$12.98 M(+40.7%) | -$38.05 M(+7.8%) |
| Jun 2015 | - | -$9.23 M(-14.8%) | -$35.29 M(+23.8%) |
| Mar 2015 | - | -$10.83 M(+116.2%) | -$28.50 M(-5.1%) |
| Dec 2014 | -$30.03 M(+378.3%) | -$5.01 M(-51.0%) | -$30.03 M(+25.9%) |
| Sep 2014 | - | -$10.22 M(+319.2%) | -$23.86 M(+54.0%) |
| Jun 2014 | - | -$2.44 M(-80.3%) | -$15.49 M(-9.2%) |
| Mar 2014 | - | -$12.36 M(-1165.5%) | -$17.05 M(+171.7%) |
| Dec 2013 | -$6.28 M(-68.4%) | $1.16 M(-162.5%) | -$6.28 M(-46.3%) |
| Sep 2013 | - | -$1.86 M(-53.6%) | -$11.70 M(-13.7%) |
| Jun 2013 | - | -$4.00 M(+152.8%) | -$13.56 M(-5.9%) |
| Mar 2013 | - | -$1.58 M(-62.9%) | -$14.40 M(-27.5%) |
| Dec 2012 | -$19.86 M(-6.4%) | -$4.26 M(+14.6%) | -$19.86 M(-3.3%) |
| Sep 2012 | - | -$3.72 M(-23.2%) | -$20.53 M(+5.4%) |
| Jun 2012 | - | -$4.84 M(-31.2%) | -$19.48 M(-27.3%) |
| Mar 2012 | - | -$7.04 M(+42.7%) | -$26.81 M(+26.4%) |
| Dec 2011 | -$21.22 M(+62.6%) | -$4.93 M(+85.3%) | -$21.22 M(+11.9%) |
| Sep 2011 | - | -$2.66 M(-78.1%) | -$18.95 M(-5.2%) |
| Jun 2011 | - | -$12.17 M(+740.1%) | -$19.98 M(+78.7%) |
| Mar 2011 | - | -$1.45 M(-45.7%) | -$11.18 M(-14.3%) |
| Dec 2010 | -$13.05 M(-35.8%) | -$2.67 M(-27.7%) | -$13.05 M(+25.7%) |
| Sep 2010 | - | -$3.69 M(+9.5%) | -$10.38 M(+55.2%) |
| Jun 2010 | - | -$3.37 M(+1.8%) | -$6.68 M(+101.8%) |
| Mar 2010 | - | -$3.31 M | -$3.31 M |
| Dec 2009 | -$20.31 M(-31.4%) | - | - |
| Dec 2008 | -$29.63 M(+30.3%) | - | - |
| Dec 2007 | -$22.73 M(-9.9%) | - | - |
| Dec 2006 | -$25.24 M | - | - |
FAQ
- What is Standard BioTools annual free cash flow?
- What is the all time high annual FCF for Standard BioTools?
- What is Standard BioTools annual FCF year-on-year change?
- What is Standard BioTools quarterly free cash flow?
- What is the all time high quarterly FCF for Standard BioTools?
- What is Standard BioTools quarterly FCF year-on-year change?
- What is Standard BioTools TTM free cash flow?
- What is the all time high TTM FCF for Standard BioTools?
- What is Standard BioTools TTM FCF year-on-year change?
What is Standard BioTools annual free cash flow?
The current annual FCF of LAB is -$46.12 M
What is the all time high annual FCF for Standard BioTools?
Standard BioTools all-time high annual free cash flow is -$6.28 M
What is Standard BioTools annual FCF year-on-year change?
Over the past year, LAB annual free cash flow has changed by +$47.08 M (+50.51%)
What is Standard BioTools quarterly free cash flow?
The current quarterly FCF of LAB is -$30.12 M
What is the all time high quarterly FCF for Standard BioTools?
Standard BioTools all-time high quarterly free cash flow is $1.16 M
What is Standard BioTools quarterly FCF year-on-year change?
Over the past year, LAB quarterly free cash flow has changed by -$15.98 M (-113.06%)
What is Standard BioTools TTM free cash flow?
The current TTM FCF of LAB is -$148.51 M
What is the all time high TTM FCF for Standard BioTools?
Standard BioTools all-time high TTM free cash flow is -$3.31 M
What is Standard BioTools TTM FCF year-on-year change?
Over the past year, LAB TTM free cash flow has changed by -$102.39 M (-222.02%)